Literature DB >> 21191773

Dendritic cells modification during sublingual immunotherapy in children with allergic symptoms to house dust mites.

Federica Angelini1, Valentina Pacciani, Stefania Corrente, Romina Silenzi, Alessandra Di Pede, Antonella Polito, Carla Riccardi, Silvia Di Cesare, Marie Laure Yammine, Paolo Rossi, Viviana Moschese, Loredana Chini.   

Abstract

BACKGROUND: the importance of dendritic cells (DCs) in the initiation of the Th2-mediated inflammatory response to allergens is well known and more recently it has been proposed that DCs have a pivotal role in maintaining tolerance to allergens. The aim of this study was to investigate whether the success of sublingual immunotherapy (SLIT) in allergic asthma is mediated by the induction of changes of DCs functions.
METHODS: ten children with allergic asthma sensitive to house dust mite were studied before and after 12 months of SLIT. Immature DCs were derived from peripheral blood monocytes cultured for 6 days in presence of interleukin (IL)-4 and GM-CSF and stimulated with lipopolysaccharide for the last 24 hours to induce maturation.
RESULTS: after 12 months of SLIT, mature DCs derived from SLIT-treated patients showed a statistically significant defect of CD86 up-regulation, an increase of IL-10, and a reduction of IL-12 production.
CONCLUSION: SLIT induces changes in DCs functions that might be responsible for an impairment of T cell activation or drive T cells towards a regulatory activity, thus restoring immune tolerance to allergens.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21191773     DOI: 10.1007/s12519-011-0242-3

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  38 in total

1.  Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo.

Authors:  Abdelilah Wakkach; Nathalie Fournier; Valérie Brun; Jean-Philippe Breittmayer; Françoise Cottrez; Hervé Groux
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

2.  Quantification of asthma control: validation of the Asthma Control Scoring System.

Authors:  A LeBlanc; P Robichaud; Y Lacasse; L-P Boulet
Journal:  Allergy       Date:  2007-02       Impact factor: 13.146

3.  Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis.

Authors:  M La Rosa; C Ranno; C André; F Carat; M A Tosca; G W Canonica
Journal:  J Allergy Clin Immunol       Date:  1999-08       Impact factor: 10.793

4.  Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics.

Authors:  M Larché; S J Till; B M Haselden; J North; J Barkans; C J Corrigan; A B Kay; D S Robinson
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

Review 5.  Tolerogenic dendritic cells: cytokine modulation comes of age.

Authors:  Sergio Rutella; Silvio Danese; Giuseppe Leone
Journal:  Blood       Date:  2006-05-09       Impact factor: 22.113

6.  IL-10-treated dendritic cells decrease airway hyperresponsiveness and airway inflammation in mice.

Authors:  Toshiyuki Koya; Hiroyuki Matsuda; Katsuyuki Takeda; Shigeki Matsubara; Nobuaki Miyahara; Annette Balhorn; Azzeddine Dakhama; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2007-03-13       Impact factor: 10.793

7.  Human peripheral blood monocyte-derived interleukin-10-induced semi-mature dendritic cells induce anergic CD4(+) and CD8(+) T cells via presentation of the internalized soluble antigen and cross-presentation of the phagocytosed necrotic cellular fragments.

Authors:  Katsuaki Sato; Naohide Yamashita; Takami Matsuyama
Journal:  Cell Immunol       Date:  2002-02       Impact factor: 4.868

Review 8.  Biology of human TH1 and TH2 cells.

Authors:  S Romagnani
Journal:  J Clin Immunol       Date:  1995-05       Impact factor: 8.317

Review 9.  T regulatory cells and their counterparts: masters of immune regulation.

Authors:  C Ozdemir; M Akdis; C A Akdis
Journal:  Clin Exp Allergy       Date:  2009-05       Impact factor: 5.018

Review 10.  Mechanisms and treatment of allergic disease in the big picture of regulatory T cells.

Authors:  Cezmi A Akdis; Mübeccel Akdis
Journal:  J Allergy Clin Immunol       Date:  2009-04       Impact factor: 10.793

View more
  7 in total

Review 1.  Applications and mechanisms of immunotherapy in allergic rhinitis and asthma.

Authors:  Jasper H Kappen; Stephen R Durham; Hans In 't Veen; Mohamed H Shamji
Journal:  Ther Adv Respir Dis       Date:  2016-09-27       Impact factor: 4.031

Review 2.  Immune mechanisms of sublingual immunotherapy.

Authors:  David C Jay; Kari C Nadeau
Journal:  Curr Allergy Asthma Rep       Date:  2014-11       Impact factor: 4.806

3.  Sublingual Immunotherapy for Asthma: Affects T-Cells but Does not Impact Basophil Activation.

Authors:  Olga Ciepiela; Anna Zawadzka-Krajewska; Iwona Kotuła; Frans van Overveld; Marek Kulus; Urszula Demkow
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-03-01       Impact factor: 1.349

4.  Development of mucosal immunity in children: a rationale for sublingual immunotherapy?

Authors:  Aleksandra Szczawinska-Poplonyk
Journal:  J Allergy (Cairo)       Date:  2011-10-27

5.  Sublingual immunotherapy for pediatric patients with mite allergies.

Authors:  Teruyuki Kajiume
Journal:  Medicine (Baltimore)       Date:  2022-01-28       Impact factor: 1.889

Review 6.  Roles of type 1 regulatory T (Tr1) cells in allergen-specific immunotherapy.

Authors:  Masaya Matsuda; Tetsuya Terada; Kazuyuki Kitatani; Ryo Kawata; Takeshi Nabe
Journal:  Front Allergy       Date:  2022-08-03

7.  Comparison between magnetic activated cell sorted monocytes and monocyte adherence techniques for in vitro generation of immature dendritic cells: an Egyptian trial.

Authors:  Sally Ahmed El-Sahrigy; Nesrine Aly Mohamed; Hala Ahmed Talkhan; Azza M Abdel Rahman
Journal:  Cent Eur J Immunol       Date:  2015-04-22       Impact factor: 2.085

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.